A new road map highlights how to overcome barriers to integrating person-centered care and evidence-based research at hospitals caring for vulnerable populations.
Historically, person-centered care and evidence-based research have not been well integrated into the hospital setting, but combining the 2 helps hospitals deliver the best care to patients. As such, America’s Essential Hospitals (AEH) used its research and education arm, Essential Hospitals Institute, to create a road map that integrates person-centered care and evidence-based research into hospital care for vulnerable patients.
The road map has been developed based on 3 advisory groups (a Patient Advisory Group,a Clinician Advisory Group, and a Chief Medical/Chief Quality Officer Advisory Group), a landscape review, a survey of America’s Essential Hospitals members, patient/caregiver interviews, and a deliberative summit hosted by the Essential Hospitals Institute and The MetroHealth System.
The research that informed the road map was conducted by the Essential Hospitals Institute and funded by the Patient-Centered Outcomes Research Institute.
The direct benefits of integrating person-centered care and evidence-based research include supporting other hospital initiatives, such as meeting patient-centered medical home certification requirements or improving quality scores and shared savings for Medicare accountable care organizations. Indirectly, integrating the 2 can mean more positive patient engagement and happier healthcare consumers.
“Person-centered care engages patients and their families as active participants and decision-makers in their own care,” Bruce Siegel, MD, MPH, president and CEO of AEH, said in a statement. “This practice not only can improve care and outcomes at essential hospitals but also can raise the standard of care for providers across the country.”
The road map identified 3 strategies to help hospitals overcome barriers to implementing person-centered care and evidence-based research. They are:
The road map also includes examples of existing programs at essential hospitals such as Henry Ford Health System, Bon Secours Health System, and The Ohio State University Wexner Medical Center.
“The vulnerable populations that essential hospitals serve often are excluded from evidence-based research,” said Kalpana Ramiah, DrPH, the Institute’s director and the association’s vice president of innovation. “By prioritizing person-centered care, engaging patients as research partners, and using research findings in shared decision-making, essential hospitals can ensure that the patients, families, and communities they serve have representation and influence in evidence-based studies.”
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More
Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care
May 26th 2023On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.
Listen
AHN’s Center for Inclusion Health Personalizing Equitable Care Delivery for Marginalized Communities
February 28th 2023On this episode of Managed Care Cast, we speak with Elizabeth Cuevas, MD, division chief of Allegheny Health Network’s (AHN) Center for Inclusion Health, on prevalent health inequities facing marginalized communities and strategies to identify and address these issues.
Listen
FDA Grants Accelerated Approval to Ponatinib Plus Chemotherapy in First-Line Ph+ ALL
March 19th 2024The FDA has granted accelerated approval to ponatinib (Iclusig) plus chemotherapy for the first-line treatment pf Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL).
Read More
6 Blood Biomarkers Identified to Predict CVD Risk in Patients With Rheumatoid Arthritis
March 15th 2024Baseline levels of serum amyloid A, C‐reactive protein, soluble tumor necrosis factor receptor 1, adiponectin, YKL‐40, and osteoprotegerin could be used to predict a rise in arterial inflammation.
Read More